AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15617591
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of daily living and work status
Trial: 12518489
Drug: Oral-B Battery
RxNorm normalized name: BATTERY,DISPOSABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Battery
Trial: 12518489
Drug: Oral-B 3-D
RxNorm normalized name: trans-resveratrol 3-β-D-glucoside
DrugBank: Polydatin (DB11263)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral-B 3-D Excel
Trial: 10354193
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment by cardiologists and general practitioners
Trial: 7853578
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg mitomycin C
Trial: 7853578
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg doxorubicin
Trial: 7853578
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment (no maintenance)
Trial: 7853578
Drug: Prolonged treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged treatment (either immediate or delayed)
Trial: 1960560
Drug: Adjuvant radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant radiation therapy (RT) to all initially involved nodal sites (total dose of 2,000 cGy, with an optional boost of 1,000 cGy)
Trial: 1960560
Drug: Partial or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial or no radiation therapy
Trial: 6121683
Drug: Beta-blocker drugs
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker drugs
Trial: 6121683
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment for mild hypertension
Trial: 21479818
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L of clear liquids (group A; 92 patients)
Trial: 21479818
Drug: 90 mL
RxNorm normalized name: 190 ML Infugem 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mL of aqueous sodium phosphate (group B; 89 patients)
Trial: 21479818
Drug: 4 L
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 L of polyethylene glycol electrolyte solution (group C; 92 patients)
Trial: 17550132
Drug: 5-FU +
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU + low-dose CDDP (n=75)
Trial: 10746493
Drug: Daily regimen:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily regimen: sulfadiazine (1 g twice a day) + 25 mg pyrimethamine + 15 mg folinic acid daily; n = 58
Trial: 10746493
Drug: Thrice-weekly regimen:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly regimen: sulfadiazine (1 g thrice a week) + 50 mg pyrimethamine + 15 mg folinic acid thrice a week; n = 66
Trial: 10746493
Drug: Not taking
RxNorm normalized name: Lamictal 25mg-100mg Tablet Starter Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not taking antiretroviral therapy
Trial: 1529149
Drug: Acyclovir 800
RxNorm normalized name: acyclovir 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 800 mg five times daily for 5 days
Trial: 27145828
Drug: Conventional periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional periodontal therapy with Er,Cr:YSGG laser application (Group 2)
Trial: 27145828
Drug: Conventional periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional periodontal therapy (Group 1)
Trial: 23821423
Drug: Rehabilitation exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation exercises (60 minutes, twice a week for 12 weeks)
Trial: 20498389
Drug: Citalopram 10
RxNorm normalized name: citalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 10 mg/d
Trial: 20498389
Drug: Citalopram 30
RxNorm normalized name: citalopram 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 30 mg/d
Trial: 19021006
Drug: 1 gr
RxNorm normalized name: Pro-Stat 101 Grape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gr i.v. paracetamol infusion 15 minutes before induction (Group I)
Trial: 19021006
Drug: i.v. Paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. Paracetamol infusion started 15 minutes before the end of surgery (Group II)
Trial: 17233365
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine administered at 8-hour intervals postoperatively
Trial: 3865492
Drug: Cefaclor (Kefolor),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (Kefolor), 20 mg/kg body weight b.i.d. for 10 days
Trial: 29108736
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose solution (2 mL of 88% sucrose)
Trial: 12401614
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 mL)
Trial: 19040446
Drug: Chinbone augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinbone augmentation with Bio-Gide membrane
Trial: 19040446
Drug: Chinbone augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinbone augmentation without Bio-Gide membrane
Trial: 19040446
Drug: Bio-Oss augmentation
RxNorm normalized name: Bio-Kool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-Oss augmentation with Bio-Gide membrane
Trial: 19040446
Drug: Combined augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined augmentation techniques
Trial: 19040446
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no augmentation techniques mentioned)
Trial: 12811710
Drug: Superactivated charcoal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superactivated charcoal (SAC) 75 g administered orally as a slurry in 8 oz of apple juice 3 hours after acetaminophen ingestion
Trial: 12811710
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no SAC administered)
Trial: 11154093
Drug: Tolcapone (TOL)
RxNorm normalized name: Tolcapone
DrugBank: Tolcapone (DB00323)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tolcapone (TOL) 600 mg
Trial: 8957270
Drug: Semilente insulin
RxNorm normalized name: INSULIN,SEMILENTE,BEEF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semilente insulin
Trial: 1530675
Drug: Product 1
RxNorm normalized name: calcium polystyrene sulfonate product 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Product 1 (20 mg nifedipine)
Trial: 1530675
Drug: Product 2
RxNorm normalized name: Cytra 2 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Product 2 (20 mg nifedipine)
Trial: 2862713
Drug: Ceftazidime (151
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (151 mg/kg every 8 hours for 12 days)
Trial: 2862713
Drug: Gentamicin and
RxNorm normalized name: Gentamicin and prednisolone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin and Carbenicillin (6.3 mg/kg gentamicin every 8 hours, 450 mg/kg carbenicillin every 6 hours for 10 days)
Trial: 31485965
Drug: Medical weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical weight management tools (partial meal replacements, recreation center vouchers, pharmacotherapy, commercial weight loss program vouchers, group behavioral weight loss program) for $5 or $10 monthly.
Trial: 31485965
Drug: On-treatment participants
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: On-treatment participants (those actively using the tools).
Trial: 29729171
Drug: Vedolizumab infusions
RxNorm normalized name: Vedolizumab
DrugBank: Vedolizumab (DB09033)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Vedolizumab infusions
Trial: 27461877
Drug: Inert cream
RxNorm normalized name: inert ingredients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert cream applied on the right hand during verbal session
Trial: 27461877
Drug: Inert cream
RxNorm normalized name: inert ingredients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert cream applied on the right hand during conditioning session
Trial: 20026457
Drug: Ramosetron 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramosetron 0.3 mg plus dexamethasone 20 mg
Trial: 20026457
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg plus dexamethasone 20 mg
Trial: 8551533
Drug: Neuromuscular biofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular biofeedback therapy
Trial: 8551533
Drug: Home exercise
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home exercise programs (post-therapy)
Trial: 24750268
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy (10000-lux light box, 30 min in the morning, three times a week for 4 weeks)
Trial: 24750268
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care without light therapy
Trial: 23803704
Drug: BHT‐3021 (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BHT‐3021 (0.3, 1.0, 3.0, and 6.0 mg)
Trial: 16730170
Drug: 750-mg levofloxacin
RxNorm normalized name: levofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750-mg levofloxacin for 5 days
Trial: 16730170
Drug: 500-mg levofloxacin
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-mg levofloxacin for 10 days
Trial: 11251523
Drug: Desmopressin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (40 microg, nasal spray)
Trial: 2801591
Drug: Multivitamin with
RxNorm normalized name: multivitamin with iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin with 18 mg Fe
Trial: 357128
Drug: Apomorphine-L-dopa-carbidopa
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Apomorphine-L-dopa-carbidopa
Trial: 31220105
Drug: γ-PGA 1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ-PGA 1,500 mg for 4 weeks
Trial: 25886286
Drug: Multi-component school-based
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-component school-based intervention including curriculum component, mandatory daily hand washing before lunch, extra cleaning of school toilets
Trial: 9000189
Drug: Nonsteroidal antiandrogens
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiandrogens (NSAAs) plus luteinizing hormone-releasing hormone (LHRH) or orchiectomy
Trial: 8229530
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose (5 ml/kg) of protein-free synthetic surfactant (Exosurf) for rescue therapy
Trial: 8229530
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose (5 ml/kg) of protein-free synthetic surfactant (Exosurf) for prophylactic therapy
Trial: 8229530
Drug: Control subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control subjects for prophylactic therapy
Trial: 8229530
Drug: Control subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control subjects for rescue therapy
Trial: 3743614
Drug: tiapamil 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiapamil 300 mg thrice daily
Trial: 26521158
Drug: Therapy devices
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy devices with varying stability properties
Trial: 22481687
Drug: Eradication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication treatment plus proton pump inhibitors
Trial: 22481687
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors alone
Trial: 16132805
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of hormone replacement therapy (HRT)
Trial: 16132805
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of hormone replacement therapy (HRT) in women aged 65+
Trial: 16132805
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of hormone replacement therapy (HRT) in women with BMI<30
Trial: 16132805
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of hormone replacement therapy (HRT) in women who regularly use aspirin or ibuprofen
Trial: 7049817
Drug: Nifedipine, 10
RxNorm normalized name: Nifedipine, 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine, 10 mg 3 times daily
Trial: 31821350
Drug: brief group-delivered
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: brief group-delivered cognitive-behavioral therapy (bCBT)
Trial: 23820061
Drug: Experimental arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental arm (treatment)
Trial: 19362552
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg/d for 8 weeks followed by 4 weeks of placebo
Trial: 17699390
Drug: AA (Nutrineal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AA (Nutrineal 1.1%) plus G (Physioneal 1.36 to 3.86%)
Trial: 15126525
Drug: AndroGel (T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AndroGel (T gel) 1% CIII, 5, 7.5, or 10 g per day for up to 42 months
Trial: 11483282
Drug: 2.5 microg
RxNorm normalized name: Digoxin 62.5 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 microg recombinant HB vaccine
Trial: 11483282
Drug: 5 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 microg recombinant HB vaccine
Trial: 11483282
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg recombinant HB vaccine
Trial: 2590612
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg daily for 12 days
Trial: 2590612
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg daily for 12 days with ranitidine 150 mg 30 min before aspirin
Trial: 2590612
Drug: Control values
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control values (no aspirin)
Trial: 21401949
Drug: Acetaminophen (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (4 g/day) for 10 days in non-drinkers (Trial 1)
Trial: 21401949
Drug: Acetaminophen (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (4 g/day) for 10 days in moderate drinkers (Trial 2)
Trial: 21401949
Drug: Acetaminophen (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (4 g/day) for 5 days in chronic alcohol abusers (Trial 3)
Trial: 21401949
Drug: Acetaminophen overdose
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen overdose (acute ingestion)
Trial: 21401949
Drug: Non-acetaminophen hepatotoxin
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-acetaminophen hepatotoxin exposure
Trial: 17436826
Drug: ER-minocycline 1
RxNorm normalized name: meclocycline
DrugBank: Meclocycline (DB13092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ER-minocycline 1 mg/kg daily
Trial: 12854893
Drug: Intrathecal (IT)
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal (IT) chemotherapy via lumbar puncture (LP) for prophylaxis
Trial: 12854893
Drug: Intrathecal (IT)
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal (IT) chemotherapy via lumbar puncture (LP) for treatment
Trial: 12854893
Drug: Systemic agents
RxNorm normalized name: ANTIACNE AGENTS,SYSTEMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic agents that cross the blood-brain barrier for prophylaxis
Trial: 12854893
Drug: Systemic agents
RxNorm normalized name: ANTIACNE AGENTS,SYSTEMIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic agents that cross the blood-brain barrier for treatment
Trial: 16229368
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment method
Trial: 12201326
Drug: 20 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 μg ethinylestradiol (EE) + 100 μg levonorgestrel (LNG)
Trial: 10030555
Drug: Topical indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical indomethacin 0.1% solution
Trial: 10030555
Drug: Topical dexamethasone
RxNorm normalized name: dexamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dexamethasone phosphate 0.1% solution
Trial: 7010995
Drug: Somatropin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin (0.1 IU/kg in three doses per week)
Trial: 7010995
Drug: Somatropin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatropin (0.1 IU/kg in three doses per week) + Oxandrolone (0.1 mg/kg/day)
Trial: 31435774
Drug: Gabapentin 300
RxNorm normalized name: gabapentin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 300 mg three times daily initially (900 mg), with 300 mg weekly incremental dose till pain was controlled, maximum daily dose of 2700 mg
Trial: 28323503
Drug: ALO 25
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALO 25 mg QD
Trial: 28323503
Drug: ALO 25
RxNorm normalized name: Aloe
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALO 25 mg QD and PIO 30 mg QD
Trial: 23472765
Drug: Trophic enteral
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trophic enteral feedings (15 mL/kg/d) during indomethacin or ibuprofen treatment (n = 81)
Trial: 23472765
Drug: No feeds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No feeds (fasting [nil per os] group) during indomethacin or ibuprofen treatment (n = 96)
Trial: 21214369
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity laser therapy (LILT) using a 630 nm diode laser
Trial: 21214369
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (Dexamethason mouth wash)
Trial: 19391533
Drug: Pecking moxibustion
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pecking moxibustion therapy
Trial: 11262983
Drug: Nimesulide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (1.5 mg/kg/dose)
Trial: 11262983
Drug: Paracetamol (10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (10.0 mg/kg/dose)
Trial: 11262983
Drug: Ibuprofen-paracetamol combination
RxNorm normalized name: ibuprofen, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen-paracetamol combination (10.0 mg/kg/dose)
Trial: 8392581
Drug: High power
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High power density (HPD) laser treatment (60 W, spot size 1-1.5 mm)
Trial: 8392581
Drug: Low power
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low power density (LPD) laser treatment (20 W, spot size 1-1.5 mm)
Trial: 3549473
Drug: sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate 1 g qid
Trial: 3549473
Drug: NSAIDs continued
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs continued during treatment
Trial: 3549473
Drug: NSAIDs stopped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs stopped during treatment
Trial: 30587217
Drug: Current standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current standard treatment
Trial: 19955694
Drug: Class Ia
RxNorm normalized name: Antiarrhythmics, class Ia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class Ia antiarrhythmic agents
Trial: 19955694
Drug: Class Ib
RxNorm normalized name: Antiarrhythmics, class Ib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class Ib antiarrhythmic agents
Trial: 19955694
Drug: Class Ic
RxNorm normalized name: Antiarrhythmics, class Ic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class Ic antiarrhythmic agents
Trial: 19955694
Drug: Class III
RxNorm normalized name: HLA class III antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class III antiarrhythmic agents